Athersys, Inc. (NASDAQ:ATHX – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. Athersys shares last traded at $0.00, with a volume of 266 shares trading hands.
Athersys Stock Down 100.0%
The stock has a market cap of $833,000.00, a PE ratio of -0.00 and a beta of -0.90.
Athersys Company Profile
Athersys, Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel regenerative medicine products. The company’s core technology platform, known as MultiStem, is an off-the-shelf, allogeneic cell therapy designed to modulate inflammation, promote tissue repair and support immune system balance. Athersys leverages its proprietary cell-culture processes and immunomodulatory capabilities to generate therapeutic candidates for a range of serious medical conditions.
MultiStem has been evaluated in multiple clinical studies targeting acute ischemic stroke, acute respiratory distress syndrome (ARDS) and inflammatory bowel disease, among other indications.
Read More
- Five stocks we like better than Athersys
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
